A historic shift in our drug policy has taken place, as the regulators allow the use of psilocybin fungi for therapeutic purposes. Previously, these substances were severely restricted, but a mounting body of evidence suggests mushrooms recalled in Canada they potentially offer relief for psychological conditions like anxiety. This change represent